GlaxoSmithKline PLC Director/PDMR Shareholding

Fecha : 11/10/2019 @ 11:34
Fuente : UK Regulatory (RNS & others)
Emisora : Glaxosmithkline Plc (GSK)
Cotización : 1722.8  4.6 (0.27%) @ 05:45
Glaxosmithkline Cotización de acciones Gráfica

GlaxoSmithKline PLC Director/PDMR Shareholding

Glaxosmithkline (LSE:GSK)
Gráfica de Acción Histórica

2 meses : De Sep 2019 a Nov 2019

Haga Click aquí para más Gráficas Glaxosmithkline.

TIDMGSK

RNS Number : 6936P

GlaxoSmithKline PLC

11 October 2019

GlaxoSmithKline plc (the 'Company')

Transaction notification

 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms E Walmsley 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Executive Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             18 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Connor 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Vaccines 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             61 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr N Hirons 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Ethics & Compliance 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             12 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms S Jackson 
====  ======================================  ================================================= 
 b)    Position/status                        SVP, Global Communications and CEO Office 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             56 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ============================================================================================== 
 a)    Name                                   Mr D Jackson 
====  ======================================  ====================================================== 
 b)    Position/status                        PCA of Mrs S Jackson (SVP, Global Communications 
                                               and CEO Office) 
====  ======================================  ====================================================== 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ====================================================== 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ============================================================================================== 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ====================================================== 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ====================================================== 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ============================================================================================== 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ====================================================== 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ====================================================== 
 c)    Price(s) and                            Price(s)                     Volume(s) 
        volume(s) 
====  ======================================   ===========================  ====================== 
   GBP17.1842                                                               19 
   =======================================================================  ====================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ====================================================================  ============================= 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ====================================================== 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ====================================================== 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr L Miels 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Pharmaceuticals 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             3 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr D Redfern 
====  ======================================  ================================================= 
 b)    Position/status                        Chief Strategy Officer 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             69 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr R Simard 
====  ======================================  ================================================= 
 b)    Position/status                        President, Pharmaceuticals Supply Chain 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             18 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Mr P C Thomson 
====  ======================================  ================================================= 
 b)    Position/status                        President, Global Affairs 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             39 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 
 
 1.    Details of PDMR/person closely associated with them 
        ('PCA') 
====  ========================================================================================= 
 a)    Name                                   Ms V A Whyte 
====  ======================================  ================================================= 
 b)    Position/status                        Company Secretary 
====  ======================================  ================================================= 
 c)    Initial notification/                  Initial notification 
        amendment 
====  ======================================  ================================================= 
 2.    Details of the issuer, emission allowance market participant, 
        auction platform, auctioneer or auction monitor 
====  ========================================================================================= 
 a)    Name                                   GlaxoSmithKline plc 
====  ======================================  ================================================= 
 b)    LEI                                    5493000HZTVUYLO1D793 
====  ======================================  ================================================= 
 3.    Details of the transaction(s): section to be repeated 
        for (i) each type of instrument; (ii) each type of transaction; 
        (iii) each date; and (iv) each place where transaction(s) 
        has been conducted 
====  ========================================================================================= 
 a)    Description of                         Ordinary shares of 25 pence each ('Ordinary 
        the financial                          Shares') 
        instrument 
                                               ISIN: GB0009252882 
====  ======================================  ================================================= 
 b)    Nature of the                          Acquisition of Ordinary Shares following 
        transaction                            the re-investment of dividends paid to 
                                               shareholders on 10 October 2019, on shares 
                                               held through the Company's Share Reward 
                                               Plan. 
====  ======================================  ================================================= 
 c)    Price(s) and                            Price(s)                   Volume(s) 
        volume(s) 
====  ======================================   =========================  =================== 
   GBP17.1842                                                             50 
   =====================================================================  =================== 
 
 d)    Aggregated information                 n/a (single transaction) 
==== 
 
    Aggregated volume 
    Price 
 ==================================================================  ========================== 
 e)    Date of the transaction                2019-10-10 
====  ======================================  ================================================= 
 f)    Place of the                           London Stock Exchange (XLON) 
        transaction 
====  ======================================  ================================================= 
 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

DSHQFLFFKBFXFBL

(END) Dow Jones Newswires

October 11, 2019 12:34 ET (16:34 GMT)

Su Consulta Reciente
BMV
FIBRAPL14
Fibra Prol..
BMV
AMXL
América Mó..
BMV
ME
IPC México
BMV
ALSEA*
Alsea
FX
USDMXN
United Sta..
Las acciones que ha visto aparecerán en este recuadro, lo que le permite volver fácilmente a las cotizaciones que ha consultado previamente
Registrarse ahora para crear su lista personalizada de acciones en streaming.

Cotizaciones PLUS están en tiempo real. Cotizaciones NYSE y AMEX están con retraso de por lo menos 20 minutos.
El resto de las cotizaciones están con retraso de por lo menos 15 minutos al menos que se indique lo contrario.

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

P: V:mx D:20191112 12:00:56